April 21, 2024 05:28 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Mamata Banerjee on DD News' new logo colour: 'Shocked at the sudden saffronisation' | Love jihad is spreading: Karnataka Congress corporator, whose daughter was killed, contradicts Siddaramaiah's claims | Karnataka Congress corporator's daughter killed; CM Siddaramaiah cites 'personal reasons' | Elon Musk postpones upcoming visit to India: Reports | 'Had mangoes only three thrice, sweets 6 times in jail': Arvind Kejriwal counters ED claims in court
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir Molnupiravir

Laurus Labs signs agreement with MPP for manufacturing Molnupiravir

India Blooms News Service | @indiablooms | 21 Jan 2022, 09:42 pm

Mumbai/UNI: Hyderabad-based Laurus Labs Limited on Friday said that it has signed an agreement with MPP (Medicine Patent Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.

Commenting on the development, Dr Satyanarayana Chava, Founder and CEO, Laurus Labs said, "We are happy to sign an agreement to manufacture the oral Covid-19 antirviral medication, which is an urgent need of the hour, this is one of the most critical step towards fighting the pandemic and we are happy to contribute to the mission."

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.